The Atossa Therapeutics (NASDAQ: ATOS) stock has emerged as one of the notable gainers this week and it is likely that the stock is soon going to gain the attention of many investors.
Yesterday, the Atossa stock soared by as high as 16.50% as investors piled on to it in a big way. However, that was not all. The rally continued during premarket trading hours today as the stock gained a further 25%.
Despite the notable gains, investors need to know that there has been no news about the company this week that could have triggered such a rally. However, towards the end of February, the company had announced the final results from the Phase 1 study of its COVID 19 nasal spray product AT 301 and the results were positive. It is meant for treating patients who are suffering from the symptoms of COVID 19. That was a significant development and might have been a factor behind the latest rally in the Atossa stock.
Finance and Tech Contributor